418 related articles for article (PubMed ID: 21537818)
1. Positive effect of modified Goeckerman regimen on quality of life and psychosocial distress in moderate and severe psoriasis.
Chern E; Yau D; Ho JC; Wu WM; Wang CY; Chang HW; Cheng YW
Acta Derm Venereol; 2011 Jun; 91(4):447-51. PubMed ID: 21537818
[TBL] [Abstract][Full Text] [Related]
2. Modern modified 'ultra' Goeckerman therapy: a PASI assessment of a very effective therapy for psoriasis resistant to both prebiologic and biologic therapies.
Lee E; Koo J
J Dermatolog Treat; 2005 Apr; 16(2):102-7. PubMed ID: 16019624
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, safety, and cost of Goeckerman therapy compared with biologics in the treatment of moderate to severe psoriasis.
de Miguel R; el-Azhary R
Int J Dermatol; 2009 Jun; 48(6):653-8. PubMed ID: 19538381
[No Abstract] [Full Text] [Related]
4. Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Fiala Z
Int J Dermatol; 2008 Aug; 47(8):800-5. PubMed ID: 18717859
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and tolerability of a cosmetically acceptable coal tar solution in the treatment of moderate plaque psoriasis: a controlled comparison with calcipotriene (calcipotriol) cream.
Alora-Palli MB; Perkins AC; Van Cott A; Kimball AB
Am J Clin Dermatol; 2010; 11(4):275-83. PubMed ID: 20513160
[TBL] [Abstract][Full Text] [Related]
6. Physical and psychologic measures are necessary to assess overall psoriasis severity.
Kirby B; Richards HL; Woo P; Hindle E; Main CJ; Griffiths CE
J Am Acad Dermatol; 2001 Jul; 45(1):72-6. PubMed ID: 11423838
[TBL] [Abstract][Full Text] [Related]
7. Crude Coal Tar and Ultraviolet (UV) A radiation (Modified Goeckerman Technique) in Treatment of Psoriasis.
El-Darouti MA; Gawdat HI; Hegazy RA; Tawdy AM; Fawzy MM; Abdel Halim DM
Acta Dermatovenerol Croat; 2015; 23(3):165-70. PubMed ID: 26476899
[TBL] [Abstract][Full Text] [Related]
8. Narrow band ultraviolet-B versus Goeckerman therapy for psoriasis with and without acitretin: A retrospective study.
Çalıskan E; Tunca M; Açıkgöz G; Arca E; Yürekli A; Akar A
Indian J Dermatol Venereol Leprol; 2015; 81(6):584-7. PubMed ID: 26515836
[TBL] [Abstract][Full Text] [Related]
9. The psoriasis disability index in Chinese patients: contribution of clinical and psychological variables.
Yang Y; Koh D; Khoo L; Nyunt SZ; Ng V; Goh CL
Int J Dermatol; 2005 Nov; 44(11):925-9. PubMed ID: 16336525
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
Thawornchaisit P; Harncharoen K
J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
[TBL] [Abstract][Full Text] [Related]
11. Ultraviolet light and tar in the Goeckerman treatment of psoriasis.
Marsico AR; Eaglstein WH; Weinstein GD
Arch Dermatol; 1976 Sep; 112(9):1249-50. PubMed ID: 793524
[TBL] [Abstract][Full Text] [Related]
12. Goeckerman treatment for remission of psoriasis refractory to biologic therapy.
Serrao R; Davis MD
J Am Acad Dermatol; 2009 Feb; 60(2):348-9. PubMed ID: 19150284
[No Abstract] [Full Text] [Related]
13. Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen.
Borska L; Fiala Z; Krejsek J; Andrys C; Vokurkova D; Hamakova K; Kremlacek J; Ettler K
Pediatr Dermatol; 2007; 24(6):607-12. PubMed ID: 18035981
[TBL] [Abstract][Full Text] [Related]
14. Successful treatment of psoriasis improves psoriasis-specific but not more general aspects of patients' well-being.
Fortune DG; Richards HL; Kirby B; McElhone K; Main CJ; Griffiths CE
Br J Dermatol; 2004 Dec; 151(6):1219-26. PubMed ID: 15606518
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
Khandpur S; Sharma VK
Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
[TBL] [Abstract][Full Text] [Related]
16. Controlled study of excimer and pulsed dye lasers in the treatment of psoriasis.
Taibjee SM; Cheung ST; Laube S; Lanigan SW
Br J Dermatol; 2005 Nov; 153(5):960-6. PubMed ID: 16225606
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen.
Borska L; Andrys C; Krejsek J; Hamakova K; Kremlacek J; Ettler K; Vellappally S; Vimal J; Fiala Z
Pediatr Dermatol; 2009; 26(1):23-7. PubMed ID: 19250400
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
Carlin CS; Callis KP; Krueger GG
Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
[TBL] [Abstract][Full Text] [Related]
19. Age, gender, quality of life and psychological distress in patients hospitalized with psoriasis.
Sampogna F; Chren MM; Melchi CF; Pasquini P; Tabolli S; Abeni D;
Br J Dermatol; 2006 Feb; 154(2):325-31. PubMed ID: 16433804
[TBL] [Abstract][Full Text] [Related]
20. A multivariate analysis of clinical severity, psychological distress and psychopathological traits in psoriatic patients.
Kotrulja L; Tadinac M; Joki-Begi NA; Gregurek R
Acta Derm Venereol; 2010 May; 90(3):251-6. PubMed ID: 20526541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
